Sarepta Therapeutics (SRPT) Gains from Sales and Divestitures (2010 - 2025)
Sarepta Therapeutics (SRPT) recorded quarterly Gains from Sales and Divestitures of $225000.0 in Q4 2025, up 491.33% quarter-over-quarter from $38050.0 in Q3 2025, and up 407.9% on a YoY basis from $44300.0 in Q4 2024.
Sarepta Therapeutics (SRPT) Gains from Sales and Divestitures (2010 - 2025) Analysis & Trends
Sarepta Therapeutics' Gains from Sales and Divestitures history runs 16 years deep, the most recent figure standing at $225000.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 407.9% year-over-year to $225000.0; the TTM figure through Dec 2025 stood at $225000.0 (up 407.9% YoY), while the FY2025 annual figure was $225000.0, up 407.9% from the prior year.
- Gains from Sales and Divestitures was $225000.0 for Q4 2025 at Sarepta Therapeutics, up from $38050.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $644614.0 in Q4 2023 to a low of $38050.0 in Q2 2025.
- Historically, Gains from Sales and Divestitures has averaged $214033.0 across 5 years, with a median of $134650.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Gains from Sales and Divestitures slumped 93.13% in 2024, then surged 407.9% in 2025.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $276980.0 in 2021, then soared by 40.72% to $389761.0 in 2022, then surged by 65.39% to $644614.0 in 2023, then slumped by 93.13% to $44300.0 in 2024, then soared by 407.9% to $225000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $225000.0 (Q4 2025), $38050.0 (Q3 2025), and $38050.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 225,000.00 |
| Dec 31, 2025 | 225,000.00 |
| Sep 30, 2025 | 38,050.00 |
| Sep 30, 2025 | 38,050.00 |
| Jun 30, 2025 | 38,050.00 |
| Jun 30, 2025 | 38,050.00 |
| Dec 31, 2024 | 44,300.00 |
| Dec 31, 2024 | 44,300.00 |
| Sep 30, 2024 | 44,300.00 |
| Sep 30, 2024 | 44,300.00 |
| Jun 30, 2024 | 44,300.00 |
| Jun 30, 2024 | 44,300.00 |
| Dec 31, 2023 | 644,614.00 |
| Dec 31, 2023 | 644,614.00 |
| Jun 30, 2023 | 394,975.00 |
| Jun 30, 2023 | 394,975.00 |
| Dec 31, 2022 | 389,761.00 |
| Dec 31, 2022 | 389,761.00 |
| Dec 31, 2021 | 276,980.00 |
| Dec 31, 2021 | 276,980.00 |